These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 21865693

  • 21. microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy.
    Liu C, Ye MY, Yan WZ, Peng XF, He LY, Peng YM.
    Front Immunol; 2020; 11():563699. PubMed ID: 33324395
    [Abstract] [Full Text] [Related]

  • 22. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S.
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [Abstract] [Full Text] [Related]

  • 23. Downregulation of the beta1,3- galactosyltransferase gene in tonsillar B lymphocytes and aberrant lectin bindings to tonsillar IgA as a pathogenesis of IgA nephropathy.
    Inoue T, Sugiyama H, Kikumoto Y, Fukuoka N, Maeshima Y, Hattori H, Fukushima K, Nishizaki K, Hiki Y, Makino H.
    Contrib Nephrol; 2007 Jun; 157():120-4. PubMed ID: 17495448
    [Abstract] [Full Text] [Related]

  • 24. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
    [Abstract] [Full Text] [Related]

  • 25. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 26. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
    Narita I, Gejyo F.
    Clin Exp Nephrol; 2008 Oct; 12(5):332-338. PubMed ID: 18404247
    [Abstract] [Full Text] [Related]

  • 27. Expression of CD19(+)CD5(+)B cells and IgA1-positive cells in tonsillar tissues of IgA nephropathy patients.
    Wu G, Peng YM, Liu H, Hou QD, Liu FY, Chen NL, Bi HX.
    Ren Fail; 2011 Oct; 33(2):159-63. PubMed ID: 21332337
    [Abstract] [Full Text] [Related]

  • 28. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 29. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D, Paradisi L, Baiocchi C, Medana C, Lo Duca G, Sena LM, Roccatello D.
    J Nephrol; 2007 Apr; 20(6):689-95. PubMed ID: 18046671
    [Abstract] [Full Text] [Related]

  • 30. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
    Xie L, Wang L, Huang J, Fan J.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):227-30. PubMed ID: 20337060
    [Abstract] [Full Text] [Related]

  • 31. [Mesangial proliferative glomerulonephritis].
    Yamada A.
    Nihon Rinsho; 2004 Oct; 62(10):1842-6. PubMed ID: 15500128
    [Abstract] [Full Text] [Related]

  • 32. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.
    Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, Cook HT, Pickering MC, Wuhrer M, Falchi M.
    J Am Soc Nephrol; 2021 Oct; 32(10):2455-2465. PubMed ID: 34127537
    [Abstract] [Full Text] [Related]

  • 33. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT, Palle S, Berthoux F.
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [Abstract] [Full Text] [Related]

  • 34. IgA production and tonsillar focal infection in IgA nephropathy.
    Meng H, Ohtake H, Ishida A, Ohta N, Kakehata S, Yamakawa M.
    J Clin Exp Hematop; 2012 Mar; 52(3):161-70. PubMed ID: 23269075
    [Abstract] [Full Text] [Related]

  • 35. Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy.
    Hiki Y, Iwase H, Saitoh M, Saitoh Y, Horii A, Hotta K, Kobayashi Y.
    Nephron; 1996 Mar; 72(3):429-35. PubMed ID: 8852492
    [Abstract] [Full Text] [Related]

  • 36. [Binding of IgA1 to monocyte/macrophage cell lines (THP-1, U937) in IgA nephropathy--a possible role of O-glycan in the IgA1 molecule].
    Horii A, Hiki Y, Saitoh M, Kanamori A, Iwase H, Hotta K, Kobayashi Y.
    Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):558-63. PubMed ID: 7474508
    [Abstract] [Full Text] [Related]

  • 37. Detection of alpha(beta)-N-acetyl-D-galactosamine-binding sites in kidney--relation to Henoch-Schönlein-associated IgA nephropathy.
    Sedivá A, Stejskal J, Bartůnková J, Smetana K, Gabius HJ.
    Folia Biol (Praha); 1999 Oct; 45(4):147-50. PubMed ID: 10732728
    [Abstract] [Full Text] [Related]

  • 38. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
    Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1106-1112. PubMed ID: 30553446
    [Abstract] [Full Text] [Related]

  • 39. Direct evidence of the production of IgA by tonsillar lymphocytes and the binding of IgA to the glomerular mesangium of IgA nephropathy patients.
    Tokuda M, Shimizu J, Sugiyama N, Kiryu T, Matsuoka K, Sasaki O, Fukuda K, Hatase O, Monden H.
    Acta Otolaryngol Suppl; 1996 Jan 22; 523():182-4. PubMed ID: 9082776
    [Abstract] [Full Text] [Related]

  • 40. Decreased CD4+CD25+ cells and increased dimeric IgA-producing cells in tonsils in IgA nephropathy.
    Huang H, Peng Y, Liu H, Yang X, Liu F.
    J Nephrol; 2010 Jan 22; 23(2):202-9. PubMed ID: 20213609
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.